Nuzenio

Trevi Therapeutics

Trevi Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 12:29:57 GMTQ2 2026 Trevi Therapeutics Inc Earnings Call Transcript - GuruFocus
Sat, 08 Aug 2026 07:14:59 GMTOppenheimer Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $25 - Moomoo
Fri, 07 Aug 2026 23:12:38 GMTTrevi Therapeutics (NASDAQ:TRVI) Announces Earnings Results, Hits Estimates - MarketBeat
Fri, 07 Aug 2026 20:34:33 GMTTrevi Therapeutics (TRVI) Starts Key Cough Trials, Is It Still 29% Below Fair Value? - simplywall.st
Fri, 07 Aug 2026 18:04:23 GMTTrevi Therapeutics Q2 Earnings Call Highlights - Yahoo Finance
Fri, 07 Aug 2026 17:20:32 GMTTrevi Therapeutics, Inc. Stock 12‑Month Price Target Raised to $29.17, Implies 58% Upside - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Trevi Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.